Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.


Autoria(s): Chartoumpekis D.V.; Sykiotis G.P.
Data(s)

2014

Identificador

https://serval.unil.ch/?id=serval:BIB_3EE4B1733A5A

isbn:1533-4406 (Electronic)

pmid:24785221

doi:

isiid:000335405200027

Idioma(s)

en

Fonte

New England Journal of Medicine, vol. 370, no. 18, pp. 1767

Palavras-Chave #Cardiovascular Diseases/mortality; Diabetes Mellitus, Type 2/complications; Diabetic Nephropathies/drug therapy; Female; Humans; Kidney Failure, Chronic/prevention & control; Male; Oleanolic Acid/analogs & derivatives; Renal Insufficiency, Chronic/drug therapy
Tipo

info:eu-repo/semantics/article

article